Full-Time

Senior Principal Biostatistician Study Lead

Oncology

Updated on 9/3/2026

ClinChoice

ClinChoice

1,001-5,000 employees

Global CRO providing full-service clinical development

No salary listed

Remote in USA

Remote

Master's, PhD

Category
Biology & Biotech (1)
Required Skills
SAS
Biostatistics
Google Cloud Platform

Get referred to ClinChoice

See people who can refer or advise you

Requirements
  • A Master of Science or Doctor of Philosophy degree in Statistics, Biostatistics, or a related field.
  • Strong experience in oncology studies.
  • Hands-on experience writing Statistical Analysis Plans and Analysis Database Specifications, and reviewing and interpreting analysis results.
  • Hands-on or strong working knowledge of SAS programming.
  • Excellent written and verbal communication skills.
  • Experience working in a contract research organization and/or pharmaceutical or biotechnology environment.
Responsibilities
  • Lead and provide statistical support for clinical studies, primarily within oncology.
  • Act as the lead statistician on assigned studies, overseeing statistical strategy and deliverables.
  • Author and review key statistical documents, including Statistical Analysis Plans, Analysis Database Specifications, and statistical sections of clinical study reports.
  • Review and interpret analysis outputs, ensuring accuracy, quality, and regulatory compliance.
  • Collaborate with cross-functional teams including Clinical, Programming, Data Management, and Regulatory.
  • Provide guidance and oversight to statistical programmers as needed.
  • Communicate statistical concepts, results, and risks clearly to both technical and non-technical stakeholders.
  • Ensure adherence to regulatory standards, including FDA, ICH, and GCP, and company standard operating procedures.
Desired Qualifications
  • Experience leading Phase II–III clinical trials.
  • Prior interaction with regulatory agencies.
  • Experience mentoring junior statisticians or programmers.

ClinChoice provides outsourced clinical development services as a global CRO for pharmaceutical, biotechnology, medical device, and consumer health clients. It supports trials across the full lifecycle with services including clinical operations, biostatistics, data management, regulatory affairs, medical affairs, pharmacovigilance, and project management, and it offers project-based or Functional Service Provider (FSP) engagement models. The company differentiates itself through its scale and international reach (4,000+ professionals in 30+ countries) and a track record of 1,500+ full-service studies, aided by growth from mergers and acquisitions. Its goal is to help clients accelerate drug and device approvals by efficiently managing multinational trials and navigating complex regulatory environments throughout development and post-marketing.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Whitemarsh Township, Pennsylvania

Founded

1995

Get referred to ClinChoice

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Monash University partnered with ClinChoice on March 23, 2026 for early-phase trials.
  • Revelio Labs reported 2,339 employees in March 2026 and 133 active 2026 postings.
  • Legend Capital's 2022 $150 million round still funds expansion and acquisition capacity.

What critics are saying

  • Revelio Labs shows active postings fell 27.8% in 2026, signaling weaker demand.
  • ClinChoice's workforce slipped from 2,348 in 2023 to 2,339 in 2026.
  • A failed integration of CROMSOURCE, CSI, and Medidata systems would break delivery quality.

What makes ClinChoice unique

  • ClinChoice spans 30+ countries, enabling multinational trials across Asia, Europe, and North America.
  • Its 2023 CROMSOURCE and 2024 CSI acquisitions deepened full-service and Southeast Asia reach.
  • The 2024 Medidata extension adds Clinical Data Studio to its data-management stack.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

7%

1 year growth

7%

2 year growth

7%
PR Newswire
Jan 12th, 2024
ClinChoice Acquires CSI, Expanding its Global Footprint into Southeast Asia

/PRNewswire/ -- ClinChoice, a leading global Contract Research Organization (CRO), today announced expanding its global footprint with the acquisition of CSI...

TalentSource Life Sciences
Mar 20th, 2023
Outsourcing in Clinical Trials Southeast 2023 – TalentSource Life Sciences

On March 1 st, 2023 ClinChoice acquired CROMSOURCE, strengthening its global network and deepening its full-service capabilities.

AVCJ
Jul 6th, 2022
Legend Capital invests into ClinChoice Inc. in $150M

US and China-based clinical contract research organization (CRO) company ClinChoice has raised a USD 150m Series E round led by Legend Capital.

Endpoints News
Jul 5th, 2022
Fountain Medical Development Ltd receives financing of $150M in Series E funding round

ClinChoice, formerly Fountain Medical Development, has completed a $150 million Series E funding round, using the cash to continue its planned expansion.

The HealthCo
Apr 13th, 2022
Cloudbyz, Inc. partnered with ClinChoice Inc. on Apr 13th 22'.

Cloudbyz, a fast-growing integrated clinical research and development solution provider with integrated capabilities, today announced a partnership with ClinChoice, a global full-service clinical CRO dedicated to offering high-quality one-stop service to biopharmaceutical, Vaccine, Medical Device, Cosmetics, Nutraceuticals, and Consumer Products clients.